Alopecia Areata: The Voice of the Patient

Condition: Alopecia

Category: Dermatology

Author:

Type: Meeting

Date: Sep 2017

A series of reports from the U.S. Food and Drug Administration’s (FDA’s) Patient-Focused Drug Development Initiative. The FDA held a public meeting to hear perspectives from patients with alopecia areata, caregivers, and other patient representatives regarding the symptoms of alopecia areata that matter most to patients and current approaches to treating this disease.

{"email":"Email address invalid","url":"Website address invalid","required":"Required field missing"}

Not Finding What You're Looking For?

Fill out the form below to let us know.

>